Jorge da Silva
Founder at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: 160 M $ as of 2024-03-30
Profile
Jorge Santos da Silva is the founder of Moonlake Immunotherapeutics AG, founded in 2021, where he holds the title of Chief Executive Officer.
He is also the founder of MoonLake Immunotherapeutics, founded in 2022, where he currently holds the title of Chief Executive Officer & Director.
Dr. da Silva's current job is as a Professor at the University of Minho, where he is currently employed.
He previously worked as a Senior Partner at McKinsey & Co., Inc. Dr. da Silva's education history includes an undergraduate degree from the University of Glasgow and a doctorate degree from the University of Turin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-14 | 2,982,814 ( 4.98% ) | 150 M $ | 2024-03-30 | |
| 2024-03-14 | 196,316 ( 2.19% ) | 10 M $ | 2024-03-30 |
Jorge da Silva active positions
| Companies | Position | Start |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Founder | 2022-04-04 |
| University of Minho | Corporate Officer/Principal | - |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Chief Executive Officer | 2021-06-30 |
Former positions of Jorge da Silva
| Companies | Position | End |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 2021-05-31 |
Training of Jorge da Silva
| University of Glasgow | Undergraduate Degree |
| University of Turin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
| MoonLake Immunotherapeutics |
- Stock Market
- Insiders
- Jorge da Silva